Carol Giltner Gallagher
CIK: 0001329959
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 8, 2026TRXB
TRex Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
17.5K shares- - Jun 4, 2026PMVP
PMV Pharmaceuticals, Inc.
Gift(G)IndirectStock Option (right to buy)
42K shares- - Jun 4, 2026PMVP
PMV Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
42K shares- - Jun 4, 2026PMVP
PMV Pharmaceuticals, Inc.
Gift(G)DirectStock Option (right to buy)
42K shares- - Jun 10, 2025ATRA
Atara Biotherapeutics, Inc.
Award(A)Direct7.8K shares- - Jun 5, 2025PMVP
PMV Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
33.5K shares- - Jun 5, 2025PMVP
PMV Pharmaceuticals, Inc.
Gift(G)DirectStock Option (right to buy)
33.5K shares- - Jun 5, 2025PMVP
PMV Pharmaceuticals, Inc.
Gift(G)IndirectStock Option (right to buy)
33.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 8, 2026 |  TRXB TRex Bio, Inc. | Award(A) Stock Option (Right to Buy) | 17,500 | - | - | Direct |
| Jun 4, 2026 |  PMVP PMV Pharmaceuticals, Inc. | Gift(G) Stock Option (right to buy) | 42,000 | - | - | Indirect |
| Jun 4, 2026 | PMVP PMV Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 42,000 | - | - | Direct |
| Jun 4, 2026 | PMVP PMV Pharmaceuticals, Inc. | Gift(G) Stock Option (right to buy) | 42,000 | - | - | Direct |
| Jun 10, 2025 |  ATRA Atara Biotherapeutics, Inc. | Award(A) | 7,828 | - | - | Direct |
| Jun 5, 2025 | PMVP PMV Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 33,500 | - | - | Direct |
| Jun 5, 2025 | PMVP PMV Pharmaceuticals, Inc. | Gift(G) Stock Option (right to buy) | 33,500 | - | - | Direct |
| Jun 5, 2025 | PMVP PMV Pharmaceuticals, Inc. | Gift(G) Stock Option (right to buy) | 33,500 | - | - | Indirect |
1-8 of 8 transactions
About Gallagher Carol Giltner
Gallagher Carol Giltner (SEC CIK 0001329959) files insider reports with the SEC as Director of TRex Bio, Inc. (TRXB), Director of PMV Pharmaceuticals, Inc. (PMVP) and Director of Atara Biotherapeutics, Inc. (ATRA).
Signal8 holds 5 ownership filings by Gallagher Carol Giltner (1 Form 3, 4 Form 4), filed between Jun 9, 2025 and Oct 8, 2026. Those filings report 8 transactions, from Jun 5, 2025 to Oct 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gallagher Carol Giltner's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Gallagher Carol Giltner
- Oct 8, 2026: Grant or award of TRXB derivative securities (Form 4, code A).
- Jun 4, 2026: Gift of PMVP derivative securities (Form 4, code G).
- Jun 4, 2026: Grant or award of PMVP derivative securities (Form 4, code A).
- Jun 4, 2026: Gift of PMVP derivative securities (Form 4, code G).
- Jun 10, 2025: Grant or award of ATRA shares (Form 4, code A).
Other insiders filing for TRex Bio, Inc. (TRXB)
- Alexandria Venture Investments, LLC, 10% Owner
- MARCUS JOEL S, Director
- SVLSF VI, LLC, 10% Owner
- Coy Travis Alan, Director
- Ross Michael Jay, Director
- Hirth Peter, Director